AI startups continue attracting record levels of investment. This week, AI drug discovery company Chai Discovery raised $400 million, while AI video generation platform PixVerse secured $439 million in fresh funding. Together, the two companies raised nearly $840 million, highlighting the continued flow of venture capital into AI-native businesses.
Chai Discovery Raises $400 Million for AI Drug Development
Chai Discovery announced a $400 million Series C funding round that values the company at approximately $3.8 billion. The round was led by Index Ventures, with participation from major investors including Kleiner Perkins, Sequoia Capital, Thrive Capital, OpenAI, and Bain Capital Ventures.
The startup develops AI models that predict how molecules interact with each other. Pharmaceutical companies use these models to accelerate drug discovery and reduce development timelines.
Chai has already partnered with major pharmaceutical companies including Eli Lilly, Pfizer, and Novartis. The company says its AI models can design new antibodies and molecules that traditional discovery methods often struggle to find.
PixVerse Secures $439 Million for AI Video Generation
AI video generation company PixVerse also announced a major funding round.
The Singapore-based startup raised $439 million in Series C financing at a valuation of approximately $2 billion. The round was led by CDH Investments and reflects growing investor confidence in AI-generated video platforms.
PixVerse develops AI tools that allow users to generate videos from text prompts, images, and other media inputs. The company operates in one of the fastest-growing segments of generative AI.
Investors Continue Backing AI-Native Companies
The latest funding announcements show that venture capital firms remain heavily focused on AI startups.
Investors are increasingly targeting businesses that build products entirely around artificial intelligence rather than simply adding AI features to existing software.
This trend has helped create a new generation of AI-native companies across healthcare, infrastructure, robotics, software development, and content creation.
Healthcare and Video Are Emerging as AI Hotspots
Drug discovery and video generation have become two of the hottest areas in artificial intelligence.
Healthcare companies see AI as a way to shorten drug development cycles and lower research costs.
Meanwhile, video generation platforms are benefiting from growing demand for content creation tools across marketing, entertainment, and social media.
The AI Funding Boom Continues
The AI investment wave shows little sign of slowing down.
Large language models initially attracted most investor attention. However, funding is now spreading across infrastructure, healthcare, robotics, and media startups.
As a result, venture firms are competing aggressively to back companies that could define the next phase of the AI industry.
Why This Matters
The success of Chai Discovery and PixVerse demonstrates an important shift in the AI market.
Investors are no longer funding only foundation model companies.
They are increasingly investing in startups that apply AI to solve specific industry problems and build new products around artificial intelligence from day one.
That trend could shape the next generation of technology leaders.
By
